HYALURONIDASE-OCSQ\OCRELIZUMAB for Multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 65 adverse event reports in the FDA FAERS database where HYALURONIDASE-OCSQ\OCRELIZUMAB was used for Multiple sclerosis.
Most Reported Side Effects for HYALURONIDASE-OCSQ\OCRELIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site erythema | 23 | 13.5% | 0 | 2 |
| Off label use | 21 | 12.3% | 0 | 1 |
| Injection site pain | 20 | 11.7% | 0 | 2 |
| Contusion | 17 | 9.9% | 0 | 1 |
| Fatigue | 17 | 9.9% | 0 | 0 |
| No adverse event | 13 | 7.6% | 0 | 0 |
| Pain | 13 | 7.6% | 0 | 0 |
| Erythema | 12 | 7.0% | 0 | 0 |
| Injection site reaction | 12 | 7.0% | 0 | 0 |
| Headache | 10 | 5.9% | 0 | 0 |
| Injection site swelling | 10 | 5.9% | 0 | 2 |
| Rash | 10 | 5.9% | 0 | 0 |
| Swelling | 8 | 4.7% | 0 | 0 |
| Pain in extremity | 7 | 4.1% | 0 | 0 |
| Multiple sclerosis relapse | 6 | 3.5% | 0 | 1 |
Other Indications for HYALURONIDASE-OCSQ\OCRELIZUMAB
Product used for unknown indication (41)
Relapsing multiple sclerosis (32)
Relapsing-remitting multiple sclerosis (20)
Primary progressive multiple sclerosis (14)
Other Drugs Used for Multiple sclerosis
DIMETHYL (78,567)
NATALIZUMAB (56,733)
INTERFERON BETA-1A (56,475)
FINGOLIMOD (43,123)
TERIFLUNOMIDE (29,963)
DALFAMPRIDINE (28,787)
GLATIRAMER (27,144)
OCRELIZUMAB (15,501)
OFATUMUMAB (11,816)
PEGINTERFERON BETA-1A (11,105)